Elanco Animal Health (ELAN) Tops Q1 EPS by 1c; Guides Q2 Lower

Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.36, $0.01 better than the analyst estimate of $0.35. Revenue for the quarter came in at $1.23 billion versus the consensus estimate of $1.22 billion.

GUIDANCE:

Elanco Animal Health sees Q2 2022 EPS of $0.22-$0.28, versus the consensus of $0.34. Elanco Animal Health sees Q2 2022 revenue of $1.16-1.2 billion, versus the consensus of $1.27 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• Audioeye, Inc. (AEYE) Misses Q2 EPS by 28c; Offer Guidance
• MDxHealth SA (MDXH) Misses Q2 EPS by 1c ; Offers Guidance
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c